---
title: "SOHAIL FAYSAL A. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/daeee7c8-99ea-56d2-aae5-75bc53f7594c
json: https://whiteintel.dev/api/public/dossier/daeee7c8-99ea-56d2-aae5-75bc53f7594c
identifier: sec:0001425394
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SOHAIL FAYSAL A.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001425394`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/daeee7c8-99ea-56d2-aae5-75bc53f7594c  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/daeee7c8-99ea-56d2-aae5-75bc53f7594c  

## Ownership & control

### Holdings / subsidiaries

- **VYNE Therapeutics Inc.** (other) — https://whiteintel.dev/entity/d382a860-279d-5548-a93d-0f56d28acd45
- **VYNE Therapeutics Inc.** (tenpercentowner) — https://whiteintel.dev/entity/d382a860-279d-5548-a93d-0f56d28acd45
- **NEOS THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/fd7737cb-d6d9-51da-8a25-e379f1a3890f
- **INTERMOLECULAR INC** (tenpercentowner) — https://whiteintel.dev/entity/334a2a39-088c-5d67-bf0c-6cf10810c073
- **INTERMOLECULAR INC** (director) — https://whiteintel.dev/entity/334a2a39-088c-5d67-bf0c-6cf10810c073
- **TETRAPHASE PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/00d77e21-49f1-5932-b731-f79704292b6b

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SOHAIL FAYSAL A.**. Human view: https://whiteintel.dev/entity/daeee7c8-99ea-56d2-aae5-75bc53f7594c · Structured JSON: https://whiteintel.dev/api/public/dossier/daeee7c8-99ea-56d2-aae5-75bc53f7594c._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._